CYPH
Price
$3.03
Change
+$0.11 (+3.77%)
Updated
Oct 2 closing price
Capitalization
356.7M
Intraday BUY SELL Signals
SABS
Price
$2.98
Change
-$0.08 (-2.61%)
Updated
Oct 2 closing price
Capitalization
292.52M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CYPH vs SABS

CYPH vs SABS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CYPH vs. SABS commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYPH is a Hold and SABS is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
CYPH: Fundamental Ratings
CYPH
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
90
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYPHSABS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
89%
Bullish Trend 15 days ago
81%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (CYPH: $2.92 vs. SABS: $3.06)
Brand notoriety: CYPH and SABS are both not notable
CYPH represents the Investment Managers, while SABS is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYPH: 141% vs. SABS: 94%
Market capitalization -- CYPH: $356.7M vs. SABS: $292.52M
CYPH [@Investment Managers] is valued at $356.7M. SABS’s [@Biotechnology] market capitalization is $292.52M. The market cap for tickers in the [@Investment Managers] industry ranges from $57 to $165.9B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Investment Managers] industry is $8.63B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYPH’s FA Score shows that 0 FA rating(s) are green while SABS’s FA Score has 0 green FA rating(s).

  • CYPH’s FA Score: 0 green, 5 red.
  • SABS’s FA Score: 0 green, 5 red.
According to our system of comparison, CYPH is a better buy in the long-term than SABS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYPH’s TA Score shows that 3 TA indicator(s) are bullish while SABS’s TA Score has 4 bullish TA indicator(s).

  • CYPH’s TA Score: 3 bullish, 6 bearish.
  • SABS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SABS is a better buy in the short-term than CYPH.

Price Growth

CYPH (@Investment Managers) experienced а -28.43% price change this week, while SABS (@Biotechnology) price change was -8.66% for the same time period.

The average weekly price growth across all stocks in the @Investment Managers industry was +1.16%. For the same industry, the average monthly price growth was +5.68%, and the average quarterly price growth was +11.79%.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

SABS is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Investment Managers (+1.16% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CYPH
Daily Signal:
Gain/Loss:
SABS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SYLD81.120.53
+0.66%
Cambria Shareholder Yield ETF (SYLD)
AESR19.970.09
+0.45%
Anfield U.S. Equity Sector Rotation ETF (AESR)
SPYG123.390.31
+0.25%
State Street SPDR Portfolio S&P 500 Growth ETF (SPYG)
MMAX27.49N/A
+0.01%
iShares Large Cap Max Buffer Mar ETF (MMAX)
NBCE37.02-0.19
-0.50%
Neuberger China Equity ETF (NBCE)

CYPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYPH has been loosely correlated with INKT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CYPH jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYPH
1D Price
Change %
CYPH100%
-12.31%
INKT - CYPH
42%
Loosely correlated
+1.43%
AXON - CYPH
40%
Loosely correlated
-0.07%
SABS - CYPH
36%
Loosely correlated
-3.47%
AMRN - CYPH
35%
Loosely correlated
-2.15%
DFDV - CYPH
32%
Poorly correlated
N/A
More

SABS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SABS has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SABS jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SABS
1D Price
Change %
SABS100%
-3.47%
REVB - SABS
48%
Loosely correlated
-1.96%
INKT - SABS
47%
Loosely correlated
+1.43%
CYPH - SABS
46%
Loosely correlated
-12.31%
TECX - SABS
35%
Loosely correlated
-2.66%
RANI - SABS
34%
Loosely correlated
+0.57%
More